Syneos Health’s 2022 Health Trends: Insights for Industry Change Agents. From patient-powered design to accelerated integration across the product lifecycle, this year’s Trends report empowers organizations to be catalysts for change by anticipating what’s to come.
Trends for 2022 focus on new models for creating stakeholder value, the importance of prioritizing human relationships at every healthcare encounter and strengthening technology-enabled insights to speed the delivery of life-changing therapies to patients.
The top 10 trends set to catalyze the year ahead align around key themes focused on Value Creation, Human Centricity and Industry Change.
Value creation: Ensuring that data and insights flow across the product lifecycle to deliver on innovation’s promise, creating greater value for all stakeholders.
Human centricity: Prioritizing the personal relationships at the core of every healthcare interaction and strengthening them with tech-enabled insights.
Industry change: Stepping up to address social policy public health issues head-on, leading by example in a newly dynamic environment for innovation.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.